로딩 중…
지수 로딩 중…
AbCellera Biologics Inc.
ABCL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
CA$5.53+1.65%
2026-06-18
Price Chart
AbCellera Biologics Inc.+59.37%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.69B |
| Revenue | $79M |
| Net Income | $-144M |
| Total Assets | $1.31B |
| Net Assets | $938M |
| Value | |
| P/B | 1.80x |
| P/S | 21.32x |
| FCF Yield | -11.21% |
| Profitability | |
| ROE | -15.35% |
| ROA | -11.01% |
| Op. Margin | -267.61% |
| Revenue Growth | 96.34% |
| Financial Health | |
| Debt Ratio | 39.34% |
| Total Debt | $140M |
| FCF | $-189M |
| Cash | $77M |
| Current Ratio | 14.05x |
| Performance | |
| 1Y Return | 59.37% |
| 1M Return | 36.54% |
| From 52W High | -18.56% |
| 1Y MDD | -54.94% |
| Trading | |
| Volume | 6,763,600 shares |
| Trading Value | $37M |
| Per Share | |
| EPS | $-0.49 |
| BPS | $3.82 |